Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-18

FDA Approved: BUMETANIDE — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved Amneal Pharmaceuticals NY LLC's original application for bumetanide, granting approval of a generic bumetanide product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUMETANIDE (bumetanide)

Snippet

ORIG AP for BUMETANIDE (BUMETANIDE)